Explore "natural oestrogens" as emerging contraceptive options - their biological basis, current evidence, safety claims, and how clinicians can guide patients through informed, evidence-based prescribing decisions.
In this Product Explainer, Gynaecologist Prof Rod Baber AM provides an update on the drospirenone 4mg progestogen-only oral contraceptive pill, including PBS information.
In this Product Explainer, Obstetrician and Gynaecologist Prof Rod Baber provides updates on doses options, PBS information and correct application of 0.1% w/w transdermal estradiol gel for the treatment of menopausal vasomotor symptoms.
In this Quick Case video, Prof Deborah Bateson presents three cases related to recent developments regarding contraception, heavy menstrual bleeding (HMB) and hormone replacement therapy (HRT) to demonstrate the impact on clinical practice
In this Product Explainer, Women’s Health Physician Dr Terri Foran explains the role of prasterone (body-identical DHEA) pessaries for the treatment of moderate to severe vulvovaginal atrophy in postmenopausal women
Over the past three years, cases of gonorrhoea have risen by 45% and chlamydia by 24%. Infectious syphilis cases have climbed steadily with 24.3 notifications per 100,000 population in 2022
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.